comparemela.com

Latest Breaking News On - Material pursuant - Page 2 : comparemela.com

National Health Investors : 2024 Supplemental Proxy

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A .

United-states
New-york
Washington
Robert-webb
Robertt-webb
D-eric-mendelsohn
Charlotte-swafford
Eric-mendelsohn
Tracy-mj-colden
Charlottea-swafford
Land-buildings-capital-management
Company-board

Pluri : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS To Be Held On June 25, 2024

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A .

Hebrew-university
Yerushalayim
Israel
United-states
Jerusalem
Israel-general
Washington
Japan
Rishon-lezion
Hamerkaz
Israeli
American

Halliburton : » Proxy Statement Supplement April 30, 2024

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy.

Texas
United-states
Houston
Washington
Delaware
Tobi-young
Alan-bennett
Institutional-shareholder-services
Halliburton-company-proxy-statement
Securities-exchange
Exchange-act
Halliburton

Lineage Cell Therapeutics : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 11, 2024, PROXY

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Schedule 14A Information .

San-diego
California
United-states
San-francisco
London
City-of
United-kingdom
San-bernardino
University-of-california-irvine
Buckinghamshire
Cambridge
Cambridgeshire

Lineage Cell Therapeutics : Additional proxy soliciting materials - definitive

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Schedule 14A Information .

United-states
Washington
Lineage-cell-therapeutics-inc
Exchange-act
Securities-exchange
Statement-pursuant
Securities-exchange-act
Commission-only
Material-pursuant
Cell-therapeutics
Its-charter

vimarsana © 2020. All Rights Reserved.